Mechanisms of proteasome inhibitor-induced cytotoxicity in malignant glioma |
| |
Authors: | Panagiotis J. Vlachostergios Ioannis A. Voutsadakis Christos N. Papandreou |
| |
Affiliation: | 1. Department of Medical Oncology, Faculty of Medicine, University of Thessaly, University Hospital of Larissa, Larissa, 41110, Greece 2. Centre Pluridisciplinaire d’ Oncologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
|
| |
Abstract: | The 26S proteasome constitutes an essential degradation apparatus involved in the consistent recycling of misfolded and damaged proteins inside cells. The aberrant activation of the proteasome has been widely observed in various types of cancers and implicated in the development and progression of carcinogenesis. In the era of targeted therapies, the clinical use of proteasome inhibitors necessitates a better understanding of the molecular mechanisms of cell death responsible for their cytotoxic action, which are reviewed here in the context of sensitization of malignant gliomas, a tumor type particularly refractory to conventional treatments. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|